UK markets open in 5 hours 38 minutes
NIKKEI 225
39,268.71 +481.33 (+1.24%) HANG SENG
19,553.61 0.00 (0.00%) CRUDE OIL
79.94 -0.12 (-0.15%) GOLD FUTURES
2,441.50 +24.10 (+1.00%) DOW
40,003.59 +134.19 (+0.34%) Bitcoin GBP
52,257.05 -444.64 (-0.84%)
Adaptimmune Therapeutics plc (ADAP)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 283.67M |
| Enterprise value | 163.71M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 13.32 |
| Price/book (mrq) | 11.64 |
| Enterprise value/revenue | 3.03 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 2.43 |
| 52-week change 3 | -13.28% |
| S&P500 52-week change 3 | 26.49% |
| 52-week high 3 | 2.0500 |
| 52-week low 3 | 0.4200 |
| 50-day moving average 3 | 1.2719 |
| 200-day moving average 3 | 0.9143 |
Share statistics
| Avg vol (3-month) 3 | 1.48M |
| Avg vol (10-day) 3 | 910.58k |
| Shares outstanding 5 | 255.56M |
| Implied shares outstanding 6 | 226.17M |
| Float 8 | 987.1M |
| % held by insiders 1 | 0.39% |
| % held by institutions 1 | 64.21% |
| Shares short (30 Apr 2024) 4 | 3.52M |
| Short ratio (30 Apr 2024) 4 | 2.76 |
| Short % of float (30 Apr 2024) 4 | 2.06% |
| Short % of shares outstanding (30 Apr 2024) 4 | 1.38% |
| Shares short (prior month 28 Mar 2024) 4 | 3.2M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 30 Mar 2018 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -188.90% |
| Operating margin (ttm) | -21,582.68% |
Management effectiveness
| Return on assets (ttm) | -28.22% |
| Return on equity (ttm) | -187.61% |
Income statement
| Revenue (ttm) | 60.28M |
| Revenue per share (ttm) | 0.30 |
| Quarterly revenue growth (yoy) | -97.90% |
| Gross profit (ttm) | N/A |
| EBITDA | -128.2M |
| Net income avi to common (ttm) | -113.87M |
| Diluted EPS (ttm) | -0.5400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 146.94M |
| Total cash per share (mrq) | 0.1 |
| Total debt (mrq) | 25.23M |
| Total debt/equity (mrq) | 63.87% |
| Current ratio (mrq) | 2.85 |
| Book value per share (mrq) | 0.17 |
Cash flow statement
| Operating cash flow (ttm) | -140.88M |
| Levered free cash flow (ttm) | -73.76M |
© 2024 Yahoo. All rights reserved.